Date of prep: December 2020
Prescribing information and
adverse events reporting
For healthcare professionals only
Dear PIP Editor,
In response to the following article:
I am very cautious and strict about codeine sales over the counter. I have seen people slide into addiction.
This story refers to codeine linctus which was supplied for the treatment of cough. I don’t feel it should be sold for this purpose.
There are a lot of other safer dry cough medications and remedies that could be used.
I have seen the same patients coming for OTC opiate containing products sometimes a few times in the same week. When challenged they get aggressive and abusive. I have also seen them go to the pharmacy next door when we refuse sales.
This problem is more widespread than people realise I think.
I think making codeine-based OTC products prescription-only would be a good idea. I think this would help make sure action is taken right at the source of the problem and addicted patients can be identified and helped.
Also, the temptation for pharmacy businesses to put profit before patient safety is restricted and stopped.
The PIP team would love to know your views on over the counter opiates. Answer the questions below and with your permission, we will publish your response to this story as a letter to the editor.
Pharmacy in Practice is a UK pharmacy publication with its roots in Scotland.